Ocean Biomedical Announces Non-Dilutive Amendment to Existing Agreement with a Key Financing Partner
03 oct. 2023 14h30 HE
|
Ocean Biomedical, Inc.
Providence, RI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA) announced today that the company and Polar Multi-Strategy Master Fund (Polar), a significant long-time...
Ocean Biomedical, Inc. Enters into a $25 Million Convertible Note Facility
16 mai 2023 08h01 HE
|
Ocean Biomedical, Inc.
Providence, RI, May 16, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development and commercialization of scientifically compelling...